Screening	Allocation	Post-allocation					Follow-up
TIMEPOINT**	-D1	D0	D1	D3	D7	D10	D14	D21	D28
ENROLMENT:
Eligibility screen	X
Informed consent	X
Allocation		X
INTERVENTIONS:
[Nafamostat mesylate]
[Standard therapy]
ASSESSMENTS:
[SARS-CoV RT-PCR]	X			X	X	X	X
[Chest X-ray]	X			X	X	X	X
[Chest CT]	X						X
[Physical examination]	X
[Viral signs]	X		X	X	X	X	X	X	X
[Symptoms]	X		X	X	X	X	X	X	X
[Seven category ordinary scale]	X		X	X	X	X	X	X	X
[NEWS score]	X				X		X	X	X
[Blood test]	X		X	X	X	X	X	X	X
[Blood collection for research]			X		X
[Adverse reaction]			X	X	X	X	X	X	X